Quantbot Technologies LP Ventyx Biosciences, Inc. Transaction History

Quantbot Technologies LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	BUY	$1.9 - $10.13 $9,836 - $52,443	5,177 New	5,177 $28,000
Q3 2023 Nov 07, 2023	SELL	$29.8 - $40.3 $243,019 - $328,646	-8,155 Reduced 42.64%	10,971 $381,000
Q2 2023 Aug 08, 2023	BUY	$28.53 - $39.55 $474,653 - $657,993	16,637 Added 668.42%	19,126 $627,000
Q1 2023 May 12, 2023	BUY	$29.51 - $46.65 $73,450 - $116,111	2,489 New	2,489 $83,000
Q3 2022 Nov 07, 2022	BUY	$12.64 - $38.7 $8,216 - $25,155	650 New	650 $22,000

125

52.9M

35.3K

83K

Ticker VTYX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,527,200
Market Cap $132M
Description
Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates for inflammatory diseases and autoimmune disorders. The company's lead product candidate is VTX958, a tyrosine kinase type 2 inhibitor that is in phase I clinical trials for the treatment of immune-mediated diseases, such as psoriasis...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.